Neogen Chemicals Q1 FY27: Revenue up 37%, PAT rises 37% YoY; board clears Rs 600 crore fundraise

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionEmphasis Of MatterExceptional ItemRelated Party TransactionsResults View source PDF

NEOGEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

—1-day move

₹2055.00

prior close

₹2135.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-3.4-3.5-2.3-1.0——————————

Up moveDown movePending

AI summary

Neogen Chemicals posted strong Q1 FY27 results. Standalone revenue rose 36.7% YoY to Rs 252.28 crore; PAT jumped 36.6% to Rs 19.44 crore. Consolidated revenue grew 34% to Rs 250.29 crore; PAT surged 66.8% to Rs 17.11 crore. Standalone operating margin expanded to 19.09% from 17.68%. Board approved raising up to Rs 600 crore via QIP or other modes. Crisil downgraded ratings on July 17; NCD coupon raised to 11% from 10.50%. Fire insurance claim of Rs 186.63 crore (standalone) still receivable from Dahej SEZ incident. 37th AGM set for August 21.

Likely market impact

Strong growth and margin expansion are positives. Watch: rating downgrade, pending fire insurance recovery, and potential Rs 600 crore equity dilution.